1. FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY. (12th June 2019) Authors: Tournilhac, O.; Truemper, L.; Ziepert, M.; Bouabdallah, K.; Nickelsen, M.; Maury, S.; Reimer, P.; Jaccard, A.; Herr, W.; Wilhelm, M.; Cartron, G.; Wulf, G.; Sanhes, L.; Dreger, P.; Lamy, T.; Kroschinsky, F.; Lindemann, H.; Roussel, M.; Viardot, A.; Sibon, D. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Human genome meeting 2016. Issue 1 (June 2016) Authors: Srivastava, A.; Wang, Y.; Huang, R.; Skinner, C.; Thompson, T.; Pollard, L.; Wood, T.; Luo, F.; Stevenson, R.; Polimanti, R.; Gelernter, J.; Lin, X.; Lim, I.; Wu, Y.; Teh, A.; Chen, L.; Aris, I.; Soh, S.; Tint, M.; MacIsaac, J. Journal: Human genomics Issue: Volume 10:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial. (29th September 2015) Authors: Hart, C.; Vogelhuber, M.; Hafner, C.; Landthaler, M.; Berneburg, M.; Haferkamp, S.; Herr, W.; Reichle, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 11(2016:Nov.) Page Start: e119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗